Entity: all
News about Gilead Sciences
ShareAnalyse the news about Gilead Sciences from multiple sources, get visualizations or extract the entire dataset.
Related dashboards:
- Gilead Sciences (organization)
Stocks making the biggest moves midday: Boeing, Nvidia, Autodesk, Gilead Sciences and more
Stocks making the biggest moves premarket: General Mills, Gilead Sciences, Tesla and more
Boeing, Nvidia, Tesla, BYD, Tencent, Gilead, General Mills, Autodesk: Stocks in view today
Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Here are Monday's biggest analyst calls: Nvidia, Apple, Amazon, Netflix, Campbell Soup, Gilead, American Express & more
Dr Reddy's, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
Stocks making the biggest moves midday: Gilead Sciences, Accenture, Trump Media, AMD and more
CymaBay shares jumped nearly 25% to hit a record after the clinical-stage biopharmaceutical company agreed to be acquired by Gilead for $4.3 billion.
CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal
CymaBay Therapeutics Shares Hit All-Time High on Gilead Deal
Stocks making the biggest moves midday: Vita Coco, Archer-Daniels-Midland, Gilead Sciences and more
Dataset
Extract all news on this scope:
Analysis
See the trend on this scope:
Evolution through time
Sources analysis:
Distribution of sources in the news
Sections analysis:
Distribution of sections in the news
Current sentiment polarity: neutral with a score of 0.2
| neutral | 61% | |
| positive | 30% | |
| negative | 9% |
Sentiment polarity through time
